Is UHS a good stock to buy? We came across a bullish thesis on Universal Health Services, Inc. on r/ValueInvesting by Dynaheir-be. In this article, we will summarize the bulls’ thesis on UHS. Universal Health Services, Inc.’s share was trading at $150.12 as of May 28th. UHS’s trailing and forward P/E were 6.44 and 6.56 respectively according to Yahoo Finance.
smart.art/Shutterstock.com
Universal Health Services (NYSE:UHS) is one of the largest for-profit hospital operators in the United States, operating acute care hospitals alongside a large behavioral health network across the US, UK, and Puerto Rico. Acute care remains the stable cash flow engine, while behavioral health provides a secular growth driver supported by rising demand for mental health services.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
The Miller family’s supervoting control structure reinforces a long-term, conservative capital allocation framework. In 2025, the company generated $17.4 billion in revenue, up 9.7%, with operating margins expanding to about 11.5% from 10.6%, reflecting pricing power and disciplined cost management.
Q1 2026 continued this momentum, with revenue up 9.6% to $4.5 billion and EPS rising to $5.65 from $4.80, while net leverage improved to 1.70x from 2.00x. Despite this strong operating performance, the stock trades at multi-year lows due to Medicaid policy fears, creating a clear disconnect between fundamentals and valuation.
Operating cash flow reached $401.6 million in Q1 2026, while capital allocation remains highly shareholder-focused, with $899 million in buybacks in 2025 and $127 million in Q1 2026, signaling management’s confidence in intrinsic value. The Talkspace acquisition expands virtual behavioral health capabilities and is expected to be accretive within a year. 2026 guidance implies $18.4 to $18.8 billion in revenue, or 6 to 8% growth, supported by improving utilization trends.
A $900 million credit capacity expansion reduces liquidity risk, while litigation and reserve charges remain largely contained within insurance coverage limits. The bull case centers on a rerating as Medicaid concerns normalize, leverage continues to decline, and earnings visibility improves, unlocking multiple expansion for a high-quality healthcare compounder trading at depressed levels despite consistent execution.
Previously, we covered a bullish thesis on DaVita Inc. (DVA) by Isaac459 in February 2025, which highlighted the potential recovery in dialysis volumes driven by improving mortality trends and post-pandemic normalization. DVA’s stock price has appreciated by approximately 14.59% since our coverage. Dynaheir-be shares a similar view but emphasizes UHS valuation disconnect, Medicaid fears, and capital allocation strength.
Universal Health Services, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 43 hedge fund portfolios held UHS at the end of the first quarter which was 50 in the previous quarter. While we acknowledge the risk and potential of UHS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UHS and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
